Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0853 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0124 | 0.5135 | 1 |
Loa Loa (eye worm) | beta-lactamase | 0.0035 | 0.0853 | 0.1661 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0853 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0035 | 0.0853 | 1 |
Toxoplasma gondii | ABC1 family protein | 0.0035 | 0.0853 | 1 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0853 | 0.1661 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0017 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0853 | 0.1661 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0124 | 0.5135 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0033 | 0.0742 | 0.1446 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0853 | 0.1661 |
Trichomonas vaginalis | esterase, putative | 0.0035 | 0.0853 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.4171 | 0.8123 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0853 | 0.1661 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0853 | 0.1661 |
Mycobacterium tuberculosis | Probable lipase LipE | 0.0035 | 0.0853 | 0.0853 |
Mycobacterium ulcerans | hypothetical protein | 0.0035 | 0.0853 | 0.5 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0033 | 0.0742 | 0.1446 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0035 | 0.0853 | 0.1661 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0742 | 0.1446 |
Echinococcus granulosus | GPCR family 2 | 0.0033 | 0.0742 | 0.1446 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0035 | 0.0853 | 0.1661 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0742 | 0.1446 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0742 | 0.1446 |
Mycobacterium tuberculosis | Conserved protein | 0.0035 | 0.0853 | 0.0853 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0071 | 0.2584 | 0.5032 |
Loa Loa (eye worm) | RNA binding protein | 0.0124 | 0.5135 | 1 |
Mycobacterium tuberculosis | Probable esterase/lipase LipP | 0.0035 | 0.0853 | 0.0853 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0033 | 0.0742 | 0.1446 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0742 | 0.1446 |
Echinococcus multilocularis | GPCR, family 2 | 0.0033 | 0.0742 | 0.1446 |
Schistosoma mansoni | tar DNA-binding protein | 0.0124 | 0.5135 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0124 | 0.5135 | 1 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0035 | 0.0853 | 0.1661 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0035 | 0.0853 | 0.1661 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0033 | 0.0742 | 0.1446 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0104 | 0.4171 | 0.8123 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0853 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0853 | 0.1661 |
Loa Loa (eye worm) | TAR-binding protein | 0.0124 | 0.5135 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0742 | 0.1446 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0035 | 0.0853 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0035 | 0.0853 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0853 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0035 | 0.0853 | 0.0853 |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0.0853 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0124 | 0.5135 | 1 |
Mycobacterium ulcerans | lipase LipD | 0.0035 | 0.0853 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0104 | 0.4171 | 0.8123 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0853 | 0.5 |
Mycobacterium tuberculosis | Probable esterase LipL | 0.0035 | 0.0853 | 0.0853 |
Mycobacterium ulcerans | beta-lactamase | 0.0035 | 0.0853 | 0.5 |
Mycobacterium tuberculosis | Probable conserved lipoprotein | 0.0035 | 0.0853 | 0.0853 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.2584 | 0.5032 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0033 | 0.0742 | 0.1446 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0033 | 0.0742 | 0.1446 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0035 | 0.0853 | 1 |
Onchocerca volvulus | 0.0035 | 0.0853 | 0.5 | |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0035 | 0.0853 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0853 | 0.1661 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0035 | 0.0853 | 0.5 |
Onchocerca volvulus | 0.0035 | 0.0853 | 0.5 | |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0033 | 0.0742 | 0.1446 |
Mycobacterium leprae | conserved hypothetical protein | 0.0035 | 0.0853 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0124 | 0.5135 | 1 |
Mycobacterium tuberculosis | Probable hydrolase | 0.0035 | 0.0853 | 0.0853 |
Schistosoma mansoni | tar DNA-binding protein | 0.0124 | 0.5135 | 1 |
Brugia malayi | beta-lactamase | 0.0035 | 0.0853 | 0.1661 |
Mycobacterium tuberculosis | Probable lipase LipD | 0.0035 | 0.0853 | 0.0853 |
Mycobacterium tuberculosis | Conserved protein | 0.0035 | 0.0853 | 0.0853 |
Brugia malayi | RNA binding protein | 0.0124 | 0.5135 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0124 | 0.5135 | 1 |
Brugia malayi | TAR-binding protein | 0.0124 | 0.5135 | 1 |
Mycobacterium tuberculosis | Possible conserved lipoprotein LpqK | 0.0035 | 0.0853 | 0.0853 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0853 | 0.1661 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0853 | 0.1661 |
Schistosoma mansoni | hypothetical protein | 0.0071 | 0.2584 | 0.5032 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0104 | 0.4171 | 0.8123 |
Schistosoma mansoni | tar DNA-binding protein | 0.0124 | 0.5135 | 1 |
Onchocerca volvulus | 0.0035 | 0.0853 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0853 | 0.1661 |
Mycobacterium leprae | Probable lipase LipE | 0.0035 | 0.0853 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 21.3313 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (binding) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.